Cargando…

Effect of Intravitreal Anti-Vascular Endothelial Growth Factor Therapy on the Risk of Arterial Thromboembolic Events: A Meta-Analysis

BACKGROUND: Intravitreal anti-vascular endothelial growth factor (VEGF) monoclonal antibodies are used in ocular neovascular diseases. A consensus has emerged that intravenous anti-VEGF can increase the risk of arterial thromboembolic events. However, the role of intravitreal anti-VEGF in arterial t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Jin-Wei, Cheng, Shi-Wei, Lu, Guo-Cai, Wei, Rui-Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3400599/ https://www.ncbi.nlm.nih.gov/pubmed/22829940 http://dx.doi.org/10.1371/journal.pone.0041325

Ejemplares similares

Systemic Outcomes of Intravitreal Injections of Dexamethasone and Anti-Vascular Endothelial Growth Factor
por: Lin, Tzu-Yi, et al.
Publicado: (2023)

Intravitreal Anti-Vascular Endothelial Growth Factor Therapies for Retinal Disorders
por: Hang, Abraham, et al.
Publicado: (2023)

Incidence of Endophthalmitis after Intravitreal Anti-Vascular Endothelial Growth Factor Injections in an Operating Room in China
por: Chen, Yanyun, et al.
Publicado: (2020)

Intravitreal Anti-Vascular Endothelial Growth Factor for Macular Edema due to Complex Retinal Arterial Macroaneurysms
por: Bormann, Caroline, et al.
Publicado: (2017)

Association between Obstetric Complications and Intravitreal Anti-Vascular Endothelial Growth Factor Agents or Intravitreal Corticosteroids
por: Ben Ghezala, Inès, et al.
Publicado: (2022)

The Association of Intravitreal Injections of Different Anti-Vascular Endothelial Growth Factor with Systemic Outcomes in Diabetic Patients
por: Kang, Eugene Yu-Chuan, et al.
Publicado: (2023)

Hemodynamic and structural changes in retinal arterial macroaneurysm after intravitreal anti-vascular endothelial growth factor injection
por: Kadomoto, Shin, et al.
Publicado: (2021)

Intravitreal Anti-vascular Endothelial Growth Factor Injection for Retinopathy of Prematurity: A Systematic Review and Meta-Analysis
por: Taher, Nada O., et al.
Publicado: (2022)

Progression of retinal vascularization after intravitreal anti-vascular-endothelial growth factor therapy in retinopathy of prematurity
por: Mirghorbani, Masoud, et al.
Publicado: (2022)

Presumed Pyogenic Granuloma Associated with Intravitreal Anti-Vascular Endothelial Growth Factor Therapy
por: Jung, Jesse J, et al.
Publicado: (2011)

Intravitreal Anti Vascular Endothelial Growth Factor Agents in The Management of Retinal Diseases: An Audit
por: Fiebai, Bassey, et al.
Publicado: (2017)

Results of Intravitreal Anti-Vascular Endothelial Growth Factor Therapy in Inflammatory Choroidal Neovascularization
por: Zina, Sourour, et al.
Publicado: (2021)

Staphylococcus lugdunensis Endophthalmitis Following Intravitreal Anti-vascular Endothelial Growth Factor Injections
por: Ahmed, Umar, et al.
Publicado: (2022)

Profile of Patients Treated with Intravitreal Anti-Vascular Endothelial Growth Factor Injections in Bhutan
por: Rai, Bhim Bahadur, et al.
Publicado: (2023)

Effect of repeated intravitreal anti-vascular endothelial growth factor drugs on corneal nerves
por: Qi, Yuanyuan, et al.
Publicado: (2023)

A meta-analysis of the effect of a dexamethasone intravitreal implant versus intravitreal anti-vascular endothelial growth factor treatment for diabetic macular edema
por: He, Ye, et al.
Publicado: (2018)

Intravitreal anti-vascular endothelial growth factor for the treatment of chronic central serous retinopathy: a meta-analysis of the literature
por: Palakkamanil, Mathew, et al.
Publicado: (2023)

Risk analysis for patients with arterial thromboembolic events after intravitreal ranibizumab or aflibercept injections
por: Chou, Yun-I., et al.
Publicado: (2023)

Intravitreal Injection of Anti-vascular Endothelial Growth Factor Agents for Ocular Vascular Diseases: Clinical Practice Guideline
por: Nikkhah, Homayoun, et al.
Publicado: (2018)

Adverse events with intravitreal injection of vascular endothelial growth factor inhibitors: nested case-control study
por: Campbell, Robert J, et al.
Publicado: (2012)

Do intravitreal anti-vascular endothelial growth factor agents lead to renal adverse events? A pharmacovigilance real-world study
por: Jiang, Lin, et al.
Publicado: (2023)

Intravitreal anti-vascular endothelial growth factor agents as an adjunct in the management of coats' disease in children
por: Kaul, Shalini, et al.
Publicado: (2010)

Intravitreal Bevacizumab as Anti-Vascular Endothelial Growth Factor in the Management of Complications of Proliferative Diabetic Retinopathy
por: Fernando Arevalo, J.
Publicado: (2013)

Incidence of Endophthalmitis after Intravitreal Anti-vascular Endothelial Growth Factor: Experience in Saudi Arabia
por: Al-Rashaed, Saba, et al.
Publicado: (2016)

Safety of bilateral same-day intravitreal injections of anti-vascular endothelial growth factor agents
por: Ruão, Miguel, et al.
Publicado: (2017)

Causative Pathogens in Endophthalmitis after Intravitreal Injection of Anti-vascular Endothelial Growth Factor Agents
por: Labardini, Cecilia P., et al.
Publicado: (2018)

Non-infectious Intraocular Inflammation Following Intravitreal Anti-Vascular Endothelial Growth Factor Injection
por: Kaya, Mahmut, et al.
Publicado: (2021)

Long-term outcome of intravitreal anti-vascular endothelial growth factor treatment for pachychoroid neovasculopathy
por: Yoon, Jihyun, et al.
Publicado: (2021)

Intravitreal anti-vascular endothelial growth factor injections to treat post-trabeculectomy Swan syndrome
por: Feu-Basilio, Silvia, et al.
Publicado: (2022)

Non-immediate drug hypersensitivity reactions secondary to intravitreal anti-vascular endothelial growth factors
por: Moret, E., et al.
Publicado: (2021)

Response to treatment with intravitreal anti-vascular endothelial growth factors in bilateral exudative cuticular drusen
por: Durlu, Yusuf K.
Publicado: (2021)

Aggravation of retinal hard exudates after intravitreal anti-vascular endothelial growth factor therapy for cystoid macular edema and the risk factors: a retrospective study
por: Shi, Rui, et al.
Publicado: (2022)

Non-adherence and non-persistence to intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy: a systematic review and meta-analysis
por: Shahzad, Haris, et al.
Publicado: (2023)

Management of Acute Submacular Hemorrhage with Intravitreal Injection of Tenecteplase, Anti-vascular Endothelial Growth Factor and Gas
por: Lee, Jung Pil, et al.
Publicado: (2016)

Endophthalmitis following intravitreal anti-vascular endothelial growth factor (VEGF) injection: a comprehensive review
por: Merani, Rohan, et al.
Publicado: (2015)

Intravitreal Anti–Vascular Endothelial Growth Factor Use in France During the Coronavirus Disease 2019 Pandemic
por: Billioti de Gage, Sophie, et al.
Publicado: (2020)

Intravitreal Anti-Vascular Endothelial Growth Factor Agents for the Treatment of Diabetic Retinopathy: A Review of the Literature
por: Chatziralli, Irini, et al.
Publicado: (2021)

EIGHTEEN-MONTH RESULTS OF INTRAVITREAL ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR ON VISION AND MICROCIRCULATION IN RADIATION MACULOPATHY
por: Eandi, Chiara M., et al.
Publicado: (2021)

Nutritionally variant streptococci causing endophthalmitis associated with intravitreal anti-vascular endothelial growth factor injection
por: Steinmetz, Robert L., et al.
Publicado: (2021)

Intravitreal anti-vascular endothelial growth factor monotherapy in age-related macular degeneration with submacular hemorrhage
por: Maruyama-Inoue, Maiko, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_srp5knl0ns2cgpvbjuv5gtuodl